Effects of protease inhibitors on replication of various myxoviruses
- PMID: 1510439
- PMCID: PMC191599
- DOI: 10.1128/AAC.36.7.1432
Effects of protease inhibitors on replication of various myxoviruses
Abstract
We studied the effects of eight protease inhibitors on the multicycle replications of various orthomyxoviruses and paramyxoviruses. Among the compounds, nafamostat mesilate, camostat mesilate, gabexate mesilate, and aprotinin, which are widely used in the treatment of pancreatitis, inhibited influenza virus A and B replication at concentrations that were significantly lower than their cytotoxic thresholds in vitro. None of the protease inhibitors had activity against respiratory syncytial virus, measles virus, or parainfluenza virus type 3 at the highest concentrations tested. Camostat mesilate was found to be the most selective inhibitor. Its 50% effective concentration for influenza virus A replication was 2.2 micrograms/ml, and the selectivity index, which was based on the ratio of the 50% inhibitory concentration for host cell proliferation to the 50% effective concentration for influenza virus A replication, was 680. When the in ovo antiviral activity of the compounds was tested by using chicken embryos, camostat mesilate at a dose of 10 micrograms/g markedly reduced the hemagglutinin titers of influenza viruses A and B.
Similar articles
-
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10. Pulm Pharmacol Ther. 2015. PMID: 26166259 Free PMC article.
-
Comparative inhibitory effects of various nucleoside and nonnucleoside analogues on replication of influenza virus types A and B in vitro and in ovo.J Infect Dis. 1993 Sep;168(3):641-6. doi: 10.1093/infdis/168.3.641. J Infect Dis. 1993. PMID: 8354905
-
[Suppression of the proteolytic activation of myxoviruses in infected chick embryos by using aprotinin].Vopr Virusol. 1985 Mar-Apr;30(2):207-14. Vopr Virusol. 1985. PMID: 2408386 Russian.
-
Aprotinin and similar protease inhibitors as drugs against influenza.Antiviral Res. 2011 Oct;92(1):27-36. doi: 10.1016/j.antiviral.2011.07.014. Epub 2011 Jul 23. Antiviral Res. 2011. PMID: 21802447 Review.
-
Strategies of development of antiviral agents directed against influenza virus replication.Curr Pharm Des. 2007;13(34):3531-42. doi: 10.2174/138161207782794248. Curr Pharm Des. 2007. PMID: 18220789 Review.
Cited by
-
Recent progress in anti-influenza chemotherapy.Drugs R D. 1999 Sep;2(3):153-64. doi: 10.2165/00126839-199902030-00001. Drugs R D. 1999. PMID: 10641217 Free PMC article. Review.
-
Novel hemagglutinin-based influenza virus inhibitors.J Thorac Dis. 2013 Aug;5 Suppl 2(Suppl 2):S149-59. doi: 10.3978/j.issn.2072-1439.2013.06.14. J Thorac Dis. 2013. PMID: 23977436 Free PMC article.
-
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.J Prev Med Hyg. 2014 Dec;55(4):109-29. J Prev Med Hyg. 2014. PMID: 26137785 Free PMC article. Review.
-
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10. Pulm Pharmacol Ther. 2015. PMID: 26166259 Free PMC article.
-
Repurposing host-based therapeutics to control coronavirus and influenza virus.Drug Discov Today. 2019 Mar;24(3):726-736. doi: 10.1016/j.drudis.2019.01.018. Epub 2019 Jan 31. Drug Discov Today. 2019. PMID: 30711575 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources